In today’s recent session, 1.25 million shares of the Vor Biopharma Inc (NASDAQ:VOR) have been traded, and its beta is -0.50. Most recently the company’s share price was $1.25, and it changed around -$0.02 or -1.97% from the last close, which brings the market valuation of the company to $129.58M. VOR at last check was trading at a discount to its 52-week high of $3.14, offering almost -151.2% off that amount. The share price’s 52-week low was $0.63, which indicates that the recent value has risen by an impressive 49.6% since then. We note from Vor Biopharma Inc’s average daily trading volume that its 10-day average is 0.95 million shares, with the 3-month average coming to 653.74K.
Vor Biopharma Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.14. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended VOR as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Vor Biopharma Inc is expected to report earnings per share of -0.31 for the current quarter.
Vor Biopharma Inc (NASDAQ:VOR) trade information
Instantly VOR has been showing red trend so far today with a performance of -1.97% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.3500 on recent trading dayincreased the stock’s daily price by 7.41%. The company’s shares are currently down -44.67% year-to-date, but still up 43.55% over the last five days. On the other hand, Vor Biopharma Inc (NASDAQ:VOR) is 57.32% up in the 30-day period. We can see from the shorts that 1.71 million shares have been sold at a short interest cover period of 2.99 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 79.17% from its current value. Analyst projections state that VOR is forecast to be at a low of $6 and a high of $6.
Vor Biopharma Inc (VOR) estimates and forecasts
Vor Biopharma Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 25.85 percent over the past six months and at a 11.43% annual growth rate that is well below the industry average of 16.70%. Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -73.43%.
VOR Dividends
Vor Biopharma Inc’s next quarterly earnings report is expected to be released in January.
Vor Biopharma Inc (NASDAQ:VOR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.17% of Vor Biopharma Inc shares, and 81.25% of them are in the hands of institutional investors. The stock currently has a share float of 82.21%. Vor Biopharma Inc stock is held by 92.0 institutions, with RA CAPITAL MANAGEMENT, L.P. being the largest institutional investor. By 2024-06-30, it held 33.439% of the shares, which is about 22.75 million shares worth $22.75 million.
FMR LLC, with 10.4009% or 7.08 million shares worth $7.08 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
